Pichiri G, Piludu M, Congiu T, Grandi N, Coni P, Piras M
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861074
PMC: 11768441.
DOI: 10.3390/ph18010011.
Syed A, Filandr F, Patterson-Fortin J, Bacolla A, Ravindranathan R, Zhou J
Nucleic Acids Res. 2023; 51(18):9920-9937.
PMID: 37665033
PMC: 10570058.
DOI: 10.1093/nar/gkad727.
Morris J, Takahashi-Ruiz L, Persi L, Summers J, McCauley E, Chan P
ACS Omega. 2022; 7(10):8824-8832.
PMID: 35309480
PMC: 8928504.
DOI: 10.1021/acsomega.1c07146.
Xie Y, Li L
Int J Mol Sci. 2022; 23(4).
PMID: 35216151
PMC: 8877516.
DOI: 10.3390/ijms23042035.
Jernigan F, Branstrom A, Baird J, Cao L, Dali M, Furia B
Mol Cancer Ther. 2021; 20(10):1846-1857.
PMID: 34315764
PMC: 9398121.
DOI: 10.1158/1535-7163.MCT-20-0774.
A substrate binding model for the KEOPS tRNA modifying complex.
Beenstock J, Ona S, Porat J, Orlicky S, Wan L, Ceccarelli D
Nat Commun. 2020; 11(1):6233.
PMID: 33277478
PMC: 7718258.
DOI: 10.1038/s41467-020-19990-5.
An intact C-terminal end of albumin is required for its long half-life in humans.
Nilsen J, Trabjerg E, Grevys A, Azevedo C, Brennan S, Stensland M
Commun Biol. 2020; 3(1):181.
PMID: 32313072
PMC: 7171077.
DOI: 10.1038/s42003-020-0903-7.
Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.
Risinger A, Du L
Nat Prod Rep. 2019; 37(5):634-652.
PMID: 31764930
PMC: 7797185.
DOI: 10.1039/c9np00053d.
Further Insight into the Interactions of the Cytotoxic Macrolides Laulimalide and Peloruside A with Their Common Binding Site.
Castro-Alvarez A, Pineda O, Vilarrasa J
ACS Omega. 2019; 3(2):1770-1782.
PMID: 31458493
PMC: 6641392.
DOI: 10.1021/acsomega.7b01723.
Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments.
Masson G, Burke J, Ahn N, Anand G, Borchers C, Brier S
Nat Methods. 2019; 16(7):595-602.
PMID: 31249422
PMC: 6614034.
DOI: 10.1038/s41592-019-0459-y.
Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
Zuniga M, Alderete J, Jana G, A Jimenez V
J Comput Aided Mol Des. 2017; 31(7):643-652.
PMID: 28597356
DOI: 10.1007/s10822-017-0029-2.
Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry.
Tsirigotaki A, Van Elzen R, Van der Veken P, Lambeir A, Economou A
Sci Rep. 2017; 7(1):2456.
PMID: 28550305
PMC: 5446394.
DOI: 10.1038/s41598-017-02550-1.
Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
Risinger A, Li J, Du L, Benavides R, Robles A, Cichewicz R
J Nat Prod. 2017; 80(2):409-414.
PMID: 28112516
PMC: 5553283.
DOI: 10.1021/acs.jnatprod.6b00944.
Novel Allosteric Pathway of Eg5 Regulation Identified through Multivariate Statistical Analysis of Hydrogen-Exchange Mass Spectrometry (HX-MS) Ligand Screening Data.
Sheff J, Farshidfar F, Bathe O, Kopciuk K, Gentile F, Tuszynski J
Mol Cell Proteomics. 2017; 16(3):428-437.
PMID: 28062800
PMC: 5341003.
DOI: 10.1074/mcp.M116.064246.
Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.
Rohena C, Telang N, Da C, Risinger A, Sikorski J, Kellogg G
Mol Pharmacol. 2015; 89(2):287-96.
PMID: 26655304
PMC: 4727124.
DOI: 10.1124/mol.115.101592.
Localizing Carbohydrate Binding Sites in Proteins Using Hydrogen/Deuterium Exchange Mass Spectrometry.
Zhang J, Kitova E, Li J, Eugenio L, Ng K, Klassen J
J Am Soc Mass Spectrom. 2015; 27(1):83-90.
PMID: 26423923
DOI: 10.1007/s13361-015-1263-2.
HX-MS2 for high performance conformational analysis of complex protein states.
Burns K, Sarpe V, Wagenbach M, Wordeman L, Schriemer D
Protein Sci. 2015; 24(8):1313-24.
PMID: 26009873
PMC: 4534182.
DOI: 10.1002/pro.2707.
Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J, Hickey J, Majumdar R, Esfandiary R, Bishop S, Samra H
MAbs. 2015; 7(3):525-39.
PMID: 25875351
PMC: 4622866.
DOI: 10.1080/19420862.2015.1029217.
Dissecting the binding mode of low affinity phage display peptide ligands to protein targets by hydrogen/deuterium exchange coupled to mass spectrometry.
Leurs U, Lohse B, Ming S, Cole P, Clausen R, Kristensen J
Anal Chem. 2014; 86(23):11734-41.
PMID: 25325890
PMC: 4255673.
DOI: 10.1021/ac503137u.
Mass spec studio for integrative structural biology.
Rey M, Sarpe V, Burns K, Buse J, Baker C, van Dijk M
Structure. 2014; 22(10):1538-48.
PMID: 25242457
PMC: 4391204.
DOI: 10.1016/j.str.2014.08.013.